for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

Onyx shuts down $10 bln offer

Posted

July 1 - Cancer drugmaker Onyx Pharmaceutical is rejecting a $10 billion takeover offer from Amgen- saying while it will sell- it's worth more. Bobbi Rebell reports.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up